Mediclinic International

From WikiMD's WELLNESSPEDIA

Mediclinicgrouplogo

Mediclinic International is a private hospital group primarily operating in South Africa, Namibia, Switzerland, and the United Arab Emirates. The company is headquartered in Stellenbosch, South Africa, and is listed on the Johannesburg Stock Exchange (JSE) and the London Stock Exchange (LSE).

History[edit]

Mediclinic International was founded in 1983 by Dr. Edwin Hertzog. The company initially focused on the South African market but has since expanded its operations internationally. In 2007, Mediclinic acquired a controlling interest in the Swiss hospital group Hirslanden, significantly increasing its footprint in Europe. In 2016, Mediclinic merged with Al Noor Hospitals Group, further expanding its presence in the Middle East.

Operations[edit]

Mediclinic International operates through three main divisions:

  • Mediclinic Southern Africa: This division manages hospitals and clinics in South Africa and Namibia.
  • Mediclinic Middle East: This division oversees operations in the United Arab Emirates, including hospitals and clinics in Dubai and Abu Dhabi.
  • Hirslanden: This division operates hospitals and clinics in Switzerland.

Services[edit]

Mediclinic International provides a wide range of healthcare services, including:

Governance[edit]

The company is governed by a Board of Directors, which includes a mix of executive and non-executive members. The current CEO is Dr. Ronnie van der Merwe, who took over the role in 2018.

Financial Performance[edit]

Mediclinic International is a publicly traded company and regularly publishes its financial results. The company has shown consistent growth over the years, driven by both organic expansion and strategic acquisitions.

Related Pages[edit]


Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Mediclinic_International&oldid=6015503"